Parkinson-kór: vizsgálatok itt: Japán
9 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleReal-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
- Where
- Bunkyo-ku, Iruma-gun, Kanagawa, Tokushima, Tokyo
- Életkor
- 18 év to 69 év
- People
- 100 worldwide
- Run by
- AbbVie
See details and how to joinNCT07227896 - 1. fázisTaking peopleA Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Where
- Hachiōji, Tōon, Yufu
- Életkor
- 30 év to 80 év
- People
- 124 worldwide
- Run by
- Prevail Therapeutics
See details and how to joinNCT06565195 · EU 2024-513411-27-00 - 1. fázisTaking peopleA Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- Where
- Hachiōji, Yufu
- Életkor
- 30 év to 85 év
- People
- 90 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06809400 - 2. fázisNot yet taking people in JapánA Study of AB-1005 Gene Therapy in Japanese Adults With Moderate Parkinson's Disease (J-REGENERATE-PD)
- Where
- Bunkyo-ku, Kyoto, Nagoya, Toyonaka, Yokohama
- Életkor
- 45 év to 75 év
- People
- 8
- Run by
- Bayer
See details and how to joinNCT07566429 - 1. fázisTaking peopleA Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)
- Where
- Sumida-ku
- Életkor
- 18 év to 85 év
- People
- 58
- Run by
- University of Shizuoka
See details and how to joinNCT07666022 - No phaseTaking peopleA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Where
- Akashi
- Életkor
- 30 év to 99 év
- People
- 60 worldwide
- Run by
- InSightec
See details and how to joinNCT05539196 - No phaseCsak meghívásosAn Observational Study of Patients With Moderate Parkinson's Disease
- Where
- Shinjuku-ku, Tokyo
- Életkor
- 50 év to 68 év
- People
- 96 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT05779475 - 1. fázisTaking peopleA Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's Disease
- Where
- Toyoake
- Életkor
- 18 év to 80 év
- People
- 24
- Run by
- Fujita Health University
See details and how to joinNCT07170475 - No phaseTaking peopleSystematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
- Where
- Gifu
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Kliniken Beelitz GmbH
See details and how to joinNCT04706234